254 related articles for article (PubMed ID: 30636056)
1. C4d detection and histological patterns in the diagnosis of antibody-mediated rejection after lung transplantation: a single-centre study.
Ngo C; Danel C; Duong-Quy S; Dauriat G; Castier Y; Lortat-Jacob B; Mal H; Brugière O; Cazes A
Histopathology; 2019 Jun; 74(7):988-996. PubMed ID: 30636056
[TBL] [Abstract][Full Text] [Related]
2. Reproducibility of Complement 4d deposition by immunofluorescence and immunohistochemistry in lung allograft biopsies.
Roden AC; Maleszewski JJ; Yi ES; Jenkins SM; Gandhi MJ; Scott JP; Aubry MC
J Heart Lung Transplant; 2014 Dec; 33(12):1223-32. PubMed ID: 25149365
[TBL] [Abstract][Full Text] [Related]
3. Acute antibody-mediated rejection after lung transplantation.
Witt CA; Gaut JP; Yusen RD; Byers DE; Iuppa JA; Bennett Bain K; Alexander Patterson G; Mohanakumar T; Trulock EP; Hachem RR
J Heart Lung Transplant; 2013 Oct; 32(10):1034-40. PubMed ID: 23953920
[TBL] [Abstract][Full Text] [Related]
4. Clinical and pathological analyses of transplant glomerulopathy cases.
Shimizu T; Ishida H; Toki D; Nozaki T; Omoto K; Tanabe K; Honda K; Koike J
Nephrology (Carlton); 2014 Jun; 19 Suppl 3():21-6. PubMed ID: 24842817
[TBL] [Abstract][Full Text] [Related]
5. C1q binding is not an independent risk factor for kidney allograft loss after an acute antibody-mediated rejection episode: a retrospective cohort study.
Moktefi A; Parisot J; Desvaux D; Canoui-Poitrine F; Brocheriou I; Peltier J; Audard V; Kofman T; Suberbielle C; Lang P; Rondeau E; Grimbert P; Matignon M
Transpl Int; 2017 Mar; 30(3):277-287. PubMed ID: 27992962
[TBL] [Abstract][Full Text] [Related]
6. The presence of anti-HLA donor-specific antibodies in lung allograft recipients does not correlate with C4d immunofluorescence in transbronchial biopsy specimens.
Roberts JA; Barrios R; Cagle PT; Ge Y; Takei H; Haque AK; Burns KM; Land GA; Dilioglou S; Bernard DW
Arch Pathol Lab Med; 2014 Aug; 138(8):1053-8. PubMed ID: 24164556
[TBL] [Abstract][Full Text] [Related]
7. Antibody-mediated rejection in the liver allograft.
Hübscher SG
Curr Opin Organ Transplant; 2012 Jun; 17(3):280-6. PubMed ID: 22569512
[TBL] [Abstract][Full Text] [Related]
8. Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.
Ali S; Ormsby A; Shah V; Segovia MC; Kantz KL; Skorupski S; Eisenbrey AB; Mahan M; Huang MA
Transpl Immunol; 2012 Jan; 26(1):62-9. PubMed ID: 21907804
[TBL] [Abstract][Full Text] [Related]
9. Free Airway C4d after Lung Transplantation - A Quantitative Analysis of Bronchoalveolar Lavage Fluid.
Heigl T; Saez-Gimenez B; Van Herck A; Kaes J; Sacreas A; Beeckmans H; Ambrocio GPL; Kwakkel-Van Erp H; Ordies S; Vanstapel A; Verleden SE; Neyrinck AP; Ceulemans LJ; Van Raemdonck DE; Verbeken E; Verleden GM; Vos R; Vanaudenaerde B
Transpl Immunol; 2021 Feb; 64():101352. PubMed ID: 33217540
[TBL] [Abstract][Full Text] [Related]
10. C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients.
Banasik M; Boratyńska M; Nowakowska B; Haloń A; Kościelska-Kasprzak K; Drulis-Fajdasz D; Patrzałek D; Weyde W; Klinger M
Transplant Proc; 2007 Nov; 39(9):2718-20. PubMed ID: 18021967
[TBL] [Abstract][Full Text] [Related]
11. Routine C4d immunohistochemistry in cardiac allografts: Long-term outcomes.
Husain AN; Mirza KM; Fedson SE
J Heart Lung Transplant; 2017 Dec; 36(12):1329-1335. PubMed ID: 28988608
[TBL] [Abstract][Full Text] [Related]
12. Application of complement component 4d immunohistochemistry to ABO-compatible and ABO-incompatible liver transplantation.
Salah A; Fujimoto M; Yoshizawa A; Yurugi K; Miyagawa-Hayashino A; Sumiyoshi S; Minamiguchi S; Uemoto S; Maekawa T; Haga H
Liver Transpl; 2014 Feb; 20(2):200-9. PubMed ID: 24470446
[TBL] [Abstract][Full Text] [Related]
13. The role of C4d deposition in the diagnosis of antibody-mediated rejection after lung transplantation.
Aguilar PR; Carpenter D; Ritter J; Yusen RD; Witt CA; Byers DE; Mohanakumar T; Kreisel D; Trulock EP; Hachem RR
Am J Transplant; 2018 Apr; 18(4):936-944. PubMed ID: 28992372
[TBL] [Abstract][Full Text] [Related]
14. Acute Cellular Rejection and C4d Positivity in Heart Transplantation : A Manifestation of Asymptomatic Antibody-Mediated Rejection?
Mohamedali B; Pyle J; Bhat G
Am J Clin Pathol; 2016 Feb; 145(2):238-43. PubMed ID: 26767383
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemistry staining of C4d to diagnose antibody-mediated rejection in cardiac transplantation.
Fedson SE; Daniel SS; Husain AN
J Heart Lung Transplant; 2008 Apr; 27(4):372-9. PubMed ID: 18374872
[TBL] [Abstract][Full Text] [Related]
16. The role of C4d immunostaining in the evaluation of the causes of renal allograft dysfunction.
Ranjan P; Nada R; Jha V; Sakhuja V; Joshi K
Nephrol Dial Transplant; 2008 May; 23(5):1735-41. PubMed ID: 18065805
[TBL] [Abstract][Full Text] [Related]
17. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
[TBL] [Abstract][Full Text] [Related]
18. The significance of C4d staining with minimal histologic abnormalities.
Haas M
Curr Opin Organ Transplant; 2010 Feb; 15(1):21-7. PubMed ID: 19907328
[TBL] [Abstract][Full Text] [Related]
19. Use of C4d as a diagnostic adjunct in lung allograft biopsies.
Magro CM; Pope Harman A; Klinger D; Orosz C; Adams P; Waldman J; Knight D; Kelsey M; Ross P
Am J Transplant; 2003 Sep; 3(9):1143-54. PubMed ID: 12919095
[TBL] [Abstract][Full Text] [Related]
20. C3d and C4d deposition early after lung transplantation.
Westall GP; Snell GI; McLean C; Kotsimbos T; Williams T; Magro C
J Heart Lung Transplant; 2008 Jul; 27(7):722-8. PubMed ID: 18582800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]